Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
A critical role for macrophages in promotion of urethane-induced lung carcinogenesis.
Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, McLoed AG, McMahon FB, Gleaves LA, Degryse AL, Stathopoulos GT, Yull FE, Blackwell TS.
J Immunol. 2011 Dec 1;187(11):5703-11. Epub 2011 Nov 2.
Related citations
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
Durgeau A, El Hage F, Vergnon I, Validire P, de Montpréville V, Besse B, Soria JC, van Hall T, Mami-Chouaib F.
J Immunol. 2011 Dec 1;187(11):5532-9. Epub 2011 Oct 24.
Induction of immunogenic apoptosis by blockade of epidermal growth factor receptor activation with a specific antibody.
Garrido G, Rabasa A, Sánchez B, López MV, Blanco R, López A, Hernández DR, Pérez R, Fernández LE.
J Immunol. 2011 Nov 15;187(10):4954-66. Epub 2011 Oct 7.
Hypoxia-inducible factor-2α regulates GM-CSF-derived soluble vascular endothelial growth factor receptor 1 production from macrophages and inhibits tumor growth and angiogenesis.
Roda JM, Sumner LA, Evans R, Phillips GS, Marsh CB, Eubank TD.
J Immunol. 2011 Aug 15;187(4):1970-6. Epub 2011 Jul 15.
Lung tumor-associated dendritic cell-derived amphiregulin increased cancer progression.
Hsu YL, Huang MS, Cheng DE, Hung JY, Yang CJ, Chou SH, Kuo PL.
J Immunol. 2011 Aug 15;187(4):1733-44. Epub 2011 Jul 8.
Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity.
Harden JL, Gu T, Kilinc MO, Rowswell-Turner RB, Virtuoso LP, Egilmez NK.
J Immunol. 2011 Jul 1;187(1):126-32. Epub 2011 Jun 1.
MUC5AC expression through bidirectional communication of Notch and epidermal growth factor receptor pathways.
Kang JH, Lee EH, Park SW, Chung IY.
J Immunol. 2011 Jul 1;187(1):222-9. Epub 2011 May 27.
Thymic stromal lymphopoietin is a key mediator of breast cancer progression.
Olkhanud PB, Rochman Y, Bodogai M, Malchinkhuu E, Wejksza K, Xu M, Gress RE, Hesdorffer C, Leonard WJ, Biragyn A.
J Immunol. 2011 May 15;186(10):5656-62. Epub 2011 Apr 13.
Tumor-produced secreted form of binding of immunoglobulin protein elicits antigen-specific tumor immunity.
Tamura Y, Hirohashi Y, Kutomi G, Nakanishi K, Kamiguchi K, Torigoe T, Sato N.
J Immunol. 2011 Apr 1;186(7):4325-30. Epub 2011 Feb 21.
NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
Salagianni M, Lekka E, Moustaki A, Iliopoulou EG, Baxevanis CN, Papamichail M, Perez SA.
J Immunol. 2011 Mar 15;186(6):3327-35. Epub 2011 Feb 11.
Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis.
Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, Voronov E, Apte RN.
J Immunol. 2011 Mar 15;186(6):3462-71. Epub 2011 Feb 7.
CCL20/CCR6 feedback exaggerates epidermal growth factor receptor-dependent MUC5AC mucin production in human airway epithelial (NCI-H292) cells.
Kim S, Lewis C, Nadel JA.
J Immunol. 2011 Mar 15;186(6):3392-400. Epub 2011 Feb 7.
Anti-NeuGcGM3 antibodies, actively elicited by idiotypic vaccination in nonsmall cell lung cancer patients, induce tumor cell death by an oncosis-like mechanism.
Hernández AM, Rodríguez N, González JE, Reyes E, Rondón T, Griñán T, Macías A, Alfonso S, Vázquez AM, Pérez R.
J Immunol. 2011 Mar 15;186(6):3735-44. Epub 2011 Feb 7.
A TCR targeting the HLA-A*0201-restricted epitope of MAGE-A3 recognizes multiple epitopes of the MAGE-A antigen superfamily in several types of cancer.
Chinnasamy N, Wargo JA, Yu Z, Rao M, Frankel TL, Riley JP, Hong JJ, Parkhurst MR, Feldman SA, Schrump DS, Restifo NP, Robbins PF, Rosenberg SA, Morgan RA.
J Immunol. 2011 Jan 15;186(2):685-96. Epub 2010 Dec 13.
Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
Kuo PL, Hung JY, Huang SK, Chou SH, Cheng DE, Jong YJ, Hung CH, Yang CJ, Tsai YM, Hsu YL, Huang MS.
J Immunol. 2011 Feb 1;186(3):1521-30. Epub 2010 Dec 29.
Enrichment of Foxp3+ CD4 regulatory T cells in migrated T cells to IL-6- and IL-8-expressing tumors through predominant induction of CXCR1 by IL-6.
Eikawa S, Ohue Y, Kitaoka K, Aji T, Uenaka A, Oka M, Nakayama E.
J Immunol. 2010 Dec 1;185(11):6734-40. Epub 2010 Nov 3.
A critical role for mast cells and mast cell-derived IL-6 in TLR2-mediated inhibition of tumor growth.
Oldford SA, Haidl ID, Howatt MA, Leiva CA, Johnston B, Marshall JS.
J Immunol. 2010 Dec 1;185(11):7067-76. Epub 2010 Nov 1.
Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion.
Ye ZJ, Zhou Q, Gu YY, Qin SM, Ma WL, Xin JB, Tao XN, Shi HZ.
J Immunol. 2010 Nov 15;185(10):6348-54. Epub 2010 Oct 15.
Plasmacytoid dendritic cells alter the antitumor activity of CpG-oligodeoxynucleotides in a mouse model of lung carcinoma.
Sorrentino R, Morello S, Luciano A, Crother TR, Maiolino P, Bonavita E, Arra C, Adcock IM, Arditi M, Pinto A.
J Immunol. 2010 Oct 15;185(8):4641-50. Epub 2010 Sep 20.
Reciprocal functional modulation of the activation of T lymphocytes and fibroblasts derived from human solid tumors.
Barnas JL, Simpson-Abelson MR, Brooks SP, Kelleher RJ Jr, Bankert RB.
J Immunol. 2010 Sep 1;185(5):2681-92. Epub 2010 Aug 4.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on